Storys zum Thema Medizin, Gesundheit

Titian Software; Labguru

Keith Hale appointed as Group CEO to Unite Titian Software & Labguru (BioData)

London (ots/PRNewswire) - Keith Hale has been appointed as Group CEO of Titian Software and Labguru (BioData Inc.), two leading providers of laboratory data management solutions, as part of the goal to accelerate the future of digital lab operations. A well-known fintech executive, Keith brings 33 years of growth-focused software and technology leadership. He ...

DYMO Deutschland

DYMO PARTNERS WITH GA INTERNATIONAL (LABTAG) TO OFFER CRYOGENIC LABELS FOR DYMO LABELWRITER 5 SERIES PRINTERS

Helmholtz Munich

Ancient Viral DNA Shapes Early Embryo Development

Over half of our genomes consists of thousands of remnants of ancient viral DNA, known as transposable elements, which are widespread across the tree of life. Once dismissed as the "dark side" of the genome, researchers at Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have now revealed their crucial role in early embryo development. Unanswered Questions About the Role of Ancient Viral DNA Transposable ...

Asklepios Kliniken GmbH & Co. KGaA

Nomination period for the Broermann Medical Innovation Award started

Gießen (ots) - - Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is ...

Aescuvest Capital Partners

Aescuvest Capital Partners (ACP) Fund Empowers Visionary Healthtech Innovators for High Returns

Munich (ots/PRNewswire) - Aescuvest Capital Partners (ACP) is at the forefront of Healthtech investing, leveraging its deep expertise in European healthcare innovation to make a global impact. With a focus on companies nearing pivotal MDR and FDA approvals, ACP is not just an investor but a catalyst for transformative change in healthcare. Over the past four years, ACP ...

Europäischer Rechnungshof - European Court of Auditors

EU city-dwellers still suffer from air and noise pollution

BAIBYS

BAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System

Tel Aviv, Israel (ots/PRNewswire) - The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market BAIBYS™, a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today announced it has received the CE mark for its innovative BAIBYS™ system. This milestone enables the company to ...

LTS Lohmann Therapie-Systeme AG

LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships

Helmholtz Munich

SCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues

Bosch Healthcare Solutions GmbH

Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

STADA Arzneimittel AG

Press Release: STADA sets course for the future - experienced healthcare manager Andreas Fibig to become Chairman of the Board

BIAL SA

BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease

Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a first-in-class, small molecule for once-daily oral ...

Norgine

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...

EU4Regions

2

5

Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality

LAUDA DR. R. WOBSER GMBH & CO. KG

Dr. Stefanie Krieger Managing Director of LAUDA Medical

LAUDA DR. R. WOBSER GMBH & CO. KG

Antonio Manconi Ten Years With LAUDA Italia

RHEACELL GmbH und Co. KG

RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers

Ottobock SE & Co. KGaA

4

Growth market for exoskeletons: “SUITX by Ottobock” expands world’s largest partner network

Gerresheimer AG

Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*

Bertelsmann Stiftung

More than half of all young people in the EU feel lonely

Gütersloh (ots) - Many young adults in the EU share the feeling that they are lonely. Around 57 per cent of young Europeans aged from 18 to 35 feel moderately or strongly lonely, according to a new Bertelsmann Stiftung study entitled “Loneliness of Young People Compared across Europe in 2024.” The data for the EU-wide survey derive from the European opinion research tool eupinions. While loneliness among young people ...

Accord Healthcare

Accord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®

London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...

Helmholtz Munich

Maria-Elena Torres-Padilla Honored With the Leibniz Prize 2025

Technische Universität München

Complex pancreatic tumor organoids as foundation for new treatment strategies

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Foundation for new cancer treatment strategies Organoids represent the complex cell landscape of pancreatic cancer - Tumors are composed of cancer cells with a variety of different characteristics. - This contributes significantly to the complexity of pancreatic cancer and makes the disease difficult to treat. - For the ...